Clinical Trial Update: Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients. [NA]

View source ↗

Summary

A completed clinical trial evaluating whether L-carnitine and Coenzyme Q10 supplementation reduce oxidative stress in Tunisian patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)
• L-carnitine (L-carnitine)

Snippet

Sponsor: University of Sfax | Conditions: Oxidative Stress Response, Hemodialysis | NA | Status: COMPLETED